PDRN is a salmon-derived DNA fragment injected into the scalp to support hair follicles rather than block hormones. Early, thin evidence from small studies points to modest gains in hair density and thickness, generally well tolerated apart from injection discomfort. Best viewed as an add-on to proven treatments — plausible but unproven. (Full Review)

Protocol

Route

Scalp injection

Intradermal/subcutaneous mesotherapy across thinning areas

Induction

3–4 sessions

Spaced 2–4 weeks apart

Maintenance

Every 3–6 months

Effect is not permanent; pattern loss continues

Time to effect

Density gains

From ~1 month

Density gains reported from about one month onward

Shaft thickness

From ~1 month

Early caliber changes, accumulating over ~3 months

Full effect

3–6 months

More visible improvement as the series completes

Benefits

Low: Increased hair density; increased hair shaft thickness; value as an add-on to existing therapy

Speculative: Reduced perifollicular inflammation and improved scalp quality; benefit in non-androgenetic or refractory alopecia

Contraindications

Pregnancy or breastfeeding

Known fish/seafood allergy

Active scalp infection, inflammation, or open wounds

Uncontrolled bleeding disorders or thrombocytopenia (<50,000/µL)

High-intensity anticoagulation with unstable control

Active scalp skin cancer or undiagnosed scalp lesions

Key Interactions

Anticoagulants and antiplatelet agents (warfarin, apixaban, rivaroxaban, clopidogrel)

Aspirin and NSAIDs (ibuprofen, naproxen)

Blood-thinning supplements (high-dose fish oil, vitamin E, ginkgo, garlic, ginger)

Other scalp procedures (laser, chemical exfoliation, hair transplantation)

Same-day injectables (platelet-rich plasma, microneedling)

Risk & Side Effects

High: Injection-site reactions

Low: Nodules, papules, or lumpiness; infection and injection-related complications; hypersensitivity / allergic reaction

Speculative: Unknown long-term safety; theoretical concerns in special populations

Monitoring

Marker	Target	Why
Ferritin	40–70 ng/mL or higher	Iron store status; low iron impairs hair growth
Vitamin D (25-OH)	40–60 ng/mL	Follicle cycling support
TSH	0.5–2.0 mIU/L	Detects thyroid dysfunction
Zinc	90–135 µg/dL	Deficiency contributes to hair loss
Total Testosterone & DHT	Sex- and age-appropriate reference range	Context for androgen-driven pattern loss

Cadence: Baseline, then ~3 months, 6 months, and every 6 months thereafter

Qualitative Assessment

Reduced daily shedding (fewer hairs on pillow/in shower/drain)
Subjective scalp coverage and fullness
Ease of styling and less visible scalp
Personal/photographic satisfaction over months

PDRN for Hair Regrowth

Protocol

Benefits

Risk & Side Effects

Monitoring

Qualitative Assessment